| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC | EVP and Chief Medical Officer | Common Stock | 130K | $4.2M | $32.28 | Feb 10, 2022 | Direct |
| Pelthos Therapeutics Inc. | Director | Restricted Stock Units | 28K | $113K | $0.97 | Jul 2, 2025 | Direct |
| Chromocell Therapeutics Corp | Director | Common Stock | 91.6K | $86.5K | $0.94 | Sep 12, 2024 | Jointly held with spouse |
| Pelthos Therapeutics Inc. | Director | Stock Option | 58.2K | Jul 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PTHS | Pelthos Therapeutics Inc. | Jul 2, 2025 | 2 | $0 | 4 | Jul 7, 2025 | Director |
| CHRO | Chromocell Therapeutics Corp | Nov 13, 2024 | 1 | $0 | 4 | Nov 15, 2024 | Director |
| CHRO | Chromocell Therapeutics Corp | Sep 12, 2024 | 1 | $9.82K | 4 | Sep 16, 2024 | Director |
| CHRO | Chromocell Therapeutics Corp | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| CHRO | Chromocell Therapeutics Corp | Feb 15, 2024 | 0 | $0 | 3 | Feb 15, 2024 | Director |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Feb 10, 2022 | 4 | -$111K | 4 | Feb 14, 2022 | EVP and Chief Medical Officer |